Your browser doesn't support javascript.
loading
Comparison of clinical outcomes in idiopathic pulmonary fibrosis patients with and without hiatal hernia.
Ayten, Ömer; Okutan, Oguzhan; Kalbaran Kismet, Gözde; Türkoglu, Özlem; Samanci, Cesur; Çaliskan, Tayfun; Canoglu, Kadir.
Afiliación
  • Ayten Ö; Clinic of Pulmonary Medicine, Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.
  • Okutan O; Clinic of Pulmonary Medicine, Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.
  • Kalbaran Kismet G; Clinic of Pulmonary Medicine, Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.
  • Türkoglu Ö; Clinic of Radiology, Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.
  • Samanci C; Department of Radiology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
  • Çaliskan T; Clinic of Pulmonary Medicine, Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.
  • Canoglu K; Clinic of Pulmonary Medicine, Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.
Tuberk Toraks ; 70(2): 113-121, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35785875
Introduction: Idiopathic pulmonary fibrosis (IPF) is a progressive disease of unknown etiology with an unpredictable course. We aimed to investigate the effects of the presence of hiatal hernia (HH) and its consequences on the clinical manifestation of IPF. Materials and Methods: Patients diagnosed with IPF with or without hiatal hernia were retrospectively compared in terms of clinical findings, total fibrosis scores (TFS), and lung function in the interstitial lung diseases (ILD) outpatient clinic. Result: A total of 142 IPF patients were included in the study. HH was detected in 62.7% (n= 89) of the patients. There was no statistically significant difference between IPF patients with or without HH in terms of age, gender, smoking history, and anti-reflux drug use (p> 0.05). There was no statistically significant difference between IPF patients with or without HH in terms of symptoms such as dyspnea, cough, regurgitation, heartburn, nausea, dysphagia, chest pain, and hoarseness (p> 0.05). In addition, no statistically significant difference was found between IPF patients with or without HH in terms of mortality rate, survival time after diagnosis, and exacerbations (p> 0.05). Six-minute walking distance and SpO2 change, percentage of predicted forced vital capacity (FVC) value, and percentage of predicted diffusing capacity for carbon monoxide (DLCO) value did not differ significantly between the groups (p> 0.05). There was no statistically significant difference between the groups in terms of total fibrosis score (p= 0.668). Conclusions: According to the results of this study, 62.7% (n= 89) of IPF patients had HH, and there was no difference in clinical outcomes, TFS, and pulmonary functions between IPF patients with or without HH.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Pulmonar Idiopática / Hernia Hiatal Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Tuberk Toraks Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Pulmonar Idiopática / Hernia Hiatal Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Tuberk Toraks Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía